Table 4 12-month and 60-month relative survival rates of SCLC patients according to SES, age group, and calendar period from 1983 to 2012 at 18 SEER sites.

From: Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages

Decade

Age Group

SES

Low Poverty

Medium Poverty

High Poverty

83–92

12-Mo RS

 Total

34.1 ± 0.5 (11460)

31.6 ± 0.5 (9074)**

28.4 ± 2.4 (366)

 0–34

42.9 ± 10.8 (21)

36.4 ± 14.5 (11)

0.0 ± 0.0 (0)

 35–49

46.7 ± 2.0 (605)

40.3 ± 2.2 (513)

37.6 ± 12.1 (16)

 50–64

40.9 ± 0.7 (4393)

37.0 ± 0.8 (3481)**

32.6 ± 3.9 (149)

 65–79

29.5 ± 0.6 (5682)

28.4 ± 0.7 (4454)

25.6 ± 3.4 (174)

 80+

17.6 ± 1.5 (759)

15.6 ± 1.5 (615)

16.1 ± 7.4 (27)

60-Mo RS

 Total

5.5 ± 0.2 (11460)

4.3 ± 0.2 (9074)***

1.8 ± 0.7 (366)*

 0–34

0.0 ± 0.0 (21)

18.3 ± 11.7 (11)

0.0 ± 0.0 (0)

 35–49

6.7 ± 1 (605)

5.2 ± 1.0 (513)

0.0 ± 0.0 (16)

 50–64

7.0 ± 0.4 (4393)

6.0 ± 0.4 (3481)

1.4 ± 1.0 (149)

 65–79

4.5 ± 0.3 (5682)

3.3 ± 0.3 (4454)*

2.6 ± 1.3 (174)

 80+

2.7 ± 0.8 (759)

0.8 ± 0.5 (615)

0.0 ± 0.0 (27)

93–02

12-Mo RS

 Total

35.1 ± 0.4 (13882)

32.1 ± 0.4 (17506)***

30.8 ± 1.0 (2228)***

 0–34

45.9 ± 10.2 (24)

50.1 ± 10.7 (22)

33.4 ± 27.2 (3)

 35–49

46.3 ± 1.8 (783)

44.1 ± 1.6 (957)

39.1 ± 3.8 (167)

 50–64

42.7 ± 0.7 (4624)

38.7 ± 0.6 (5854)***

37.0 ± 1.7 (821)*

 65–79

32.0 ± 0.6 (7049)

29.1 ± 0.5 (8956)**

27.1 ± 1.4 (1053)*

 80+

18.2 ± 1.1 (1402)

17.7 ± 1.0 (1717)

16.6 ± 2.9 (184)

60-Mo RS

 Total

6.6 ± 0.2 (13882)

5.6 ± 0.2 (17506)**

4.2 ± 0.4 (2228)***

 0–34

12.5 ± 6.8 (24)

13.7 ± 7.3 (22)

0.0 ± 0.0 (3)

 35–49

10.7 ± 1.1 (783)

8.3 ± 0.9 (957)

4.9 ± 1.7 (167)

 50–64

8.7 ± 0.4 (4624)

7.3 ± 0.4 (5854)

5.5 ± 0.8 (821)*

 65–79

5.3 ± 0.3 (7049)

4.7 ± 0.2 (8956)

3.4 ± 0.6 (1053)

 80+

3.2 ± 0.6 (1402)

2.6 ± 0.5 (1717)

1.7 ± 1.2 (184)

03–12

12-Mo RS

 Total

34.9 ± 0.4 (17819)

32.5 ± 0.3 (26739)***

31.3 ± 0.6 (6045)***

 0–34

83.4 ± 10.8 (12)

67.1 ± 9.6 (25)

57.2 ± 18.7 (7)

 35–49

50.4 ± 1.7 (905)

42.7 ± 1.4 (1346)**

43.2 ± 2.5 (401)

 50–64

42.4 ± 0.6 (6226)

39.2 ± 0.5 (9622)***

36.9 ± 1.0 (2379)***

 65–79

31.8 ± 0.5 (8442)

29.9 ± 0.4 (12690)*

27.5 ± 0.9 (2765)***

 80+

18.7 ± 0.9 (2234)

17.0 ± 0.7 (3056)

14.8 ± 1.7 (493)

60-Mo RS

 Total

6.9 ± 0.2 (17819)

6.2 ± 0.2 (26739)

5.7 ± 0.3 (6045)*

 0–34

16.7 ± 10.8 (12)

7.2 ± 6.6 (25)

57.2 ± 18.7 (7)

 35–49

12.3 ± 1.2 (905)

9.4 ± 0.9 (1346)

8.8 ± 1.6 (401)

 50–64

9.1 ± 0.4 (6226)

7.9 ± 0.3 (9622)

6.6 ± 0.6 (2379)**

 65–79

5.5 ± 0.3 (8442)

5.3 ± 0.2 (12690)

4.9 ± 0.5 (2765)

 80+

3.6 ± 0.6 (2234)

2.2 ± 0.4 (3056)

2.2 ± 1 (493)

  1. Data are means ± standard error of the mean, with number of patients in parentheses. Abbreviations: Mo, month; RS, relative survival; SEM, standard error of the mean. *p < 0.01, **p < 0.001, and ***p < 0.0001 for comparisons with the Low Poverty group.
Back to article page